Duzallo Combines Lesinurad and Allopurinol in One Tab for Gout

Duzallo (doo-ZAL-oh) will be a new chronic gout med that combines lesinurad with allopurinol.

Duzallo is an option for patients who still have gout flares with max tolerated doses of allopurinol.

Be careful when documenting doses on med histories. There are two similar-looking strengths of Duzallo (lesinurad/allopurinol)... 200/200 mg and 200/300 mg.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals